e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular risk detection in COPD
R. Böcskei (Budapest, Hungary), B. Benczúr (Szekszárd, Hungary), A. Bikov (Budapest, Hungary), C. Böcskei (Tatabánya, Hungary), A. Bohács (Budapest, Hungary), V. Müller (Budapest, Hungary)
Source:
International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session:
Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session type:
Poster Discussion
Number:
5016
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Böcskei (Budapest, Hungary), B. Benczúr (Szekszárd, Hungary), A. Bikov (Budapest, Hungary), C. Böcskei (Tatabánya, Hungary), A. Bohács (Budapest, Hungary), V. Müller (Budapest, Hungary). Cardiovascular risk detection in COPD. 5016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020
Cardiovascular risk and exercise capacity in COPD
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Global cardiovascular disease risk in U.S. adults by severity and presence of COPD
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020
Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015
Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Modifiable risk factors for all-cause hospitalization in obstructive lung disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Prevalence of cardiovascular disease in COPD patients in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Microalbuminuria as a cardiovascular biomarker in patients with COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Correlates and assessment of excess cardiovascular risk in bronchiectasis
Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017
Year: 2017
Screening for the risk of malnutrition in COPD patients
Source: Annual Congress 2008 - Impact of nursing interventions on the quality of care for COPD patients
Year: 2008
Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept